Equibles does not estimate personal net worth.
Get an email with a short summary when Rani Therapeutics Holdings, Inc. publishes a filing, an earnings call transcript or a press release.
Get RANI alertsNicholas M. Maestas is recorded as CFO at Rani Therapeutics Holdings, Inc. (RANI) since June 29, 2026. Rani Therapeutics Holdings, Inc. reported in an 8-K filed June 30, 2026 that Nicholas M. Maestas was appointed Chief Financial Officer (principal financial officer and principal accounting officer), effective June 29, 2026. Nicholas M. Maestas has spoken on 2 investor events across 1 company, most recently for Rani Therapeutics Holdings, Inc. on October 20, 2026. Rani Therapeutics Holdings, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Rani Therapeutics Holdings, Inc. includes Lisa Rometty (CEO), Talat Imran (CEO and Board Member), Mir Imran (Chairman) and 7 others.
“On June 29, 2026, Rani Therapeutics Holdings, Inc. (the “Company”) announced the appointment of Nicholas M. Maestas as the Company’s Chief Financial Officer (principal financial officer and principal accounting officer) effective as of June 29, 2026.”
“So we reported, our last reported was Q1, Q2 upcoming, but 43 million in cash and marketable securities. At the time, that was runway into Q4 of 2027, which is enough to get us past these catalysts with Buffer on the other side.”
2026-06-29–present
Biotechnology · Healthcare
CFO
2026-06-29–present
